Celsion Corporate Presentation/Fireside Chat at Chardan 5th Annual Genetic Medicines Conference

Celsion Corporate Presentation_September 2021_HCW Global Investment Conference 9

Celsion Corporation Second Quarter 2021 Earnings Call

Celsion Corporate Presentation - July 2021

33rd Annual Roth Conference Celsion Corporate Presentation

Celsion Corporation Conference Call to Discuss OPTIMA Study

Chardan’s 3rd Annual Genetic Medicines Conference

Celsion Corporate Presentation - The ThinkEquity Conference

Celsion Corporate Presentation - 29th Annual Oppenheimer Healthcare Conference

Celsion Corporation Presents at the RHK Capital 2018 Disruptive Growth and Healthcare Conference

Research and Development Day

Presentation at the International Liver Cancer Association 2015 Annual Conference on September 5, 2015 by Dr. Ronnie T.P. Poon entitled ""Current Management of Intermediate HCC: Unmet Medical Needs."

Presentation at the International Liver Cancer Association 2015 Annual Conference on September 5, 2015 by Professor Riccardo Lencioni entitled "OPTIMA Phase III Clinical Trial: Study Design and Protocol."

Presentation at the International Liver Cancer Association 2015 Annual Conference on September 5, 2015 by Dr. Ghassan K. Abou-Alfa entitled "Intermediate HCC Treatment Paradigms and Lessons Learned."

Presentation at the Molecular Medicine TRI-Conference on February 20, 2015 by Dr. Khursheed Anwer titled "Development of a Novel IL-12 DNA-based Immunotherapy in Combination with Chemotherapy for Treatment of Advanced Ovarian Cancer."

Presentation at the International Liver Cancer Association 2014 Annual Conference on September 6, 2014 by Professor Riccardo Lencioni titled "Image Guided Ablations: Current Status and Future Prospects"

Presentation at the International Liver Cancer Association 2014 Annual Conference on September 6, 2014 by Professor Ronnie T.P. Poon titled "New Paradigms in Staging HCC: BCLC vs. Hong Kong Liver Cancer Staging System (HKLS)"

Presentation at the International Liver Cancer Association 2014 Annual Conference on September 6, 2014 by Dr. Richard Finn titled "Phase III Studies in Intermediate Stage HCC: What Have We Learned From Recent Failures"

Presentation at the 14th Annual Symposium on Therapeutic Ultrasound in Las Vegas, NV on April 5, 2014 by Dr. Mark Dewhirst – "Use of Thermosensitive Liposomes in Combination with Ultrasound"

Novel Targeted Therapy for Breast Cancer Chest Wall Recurrence Poster Presentation by Prof Hope S. Rugo, MD at the 2013 San Antonio Breast Cancer Conference.

Presentation at the 2013 International Liver Cancer Association (ILCA) Conference on September 14, 2013 by Professor Ronnie T.P. Poon, MD, PhD.

Presentation at The European Conference on Interventional Oncology (ECIO) by Professor Riccardo Lencioni, MD New Horizons: Thermally Sensitive Doxorubicin Carriers

Presentation at The European Conference on Interventional Oncology (ECIO) by Professor Riccardo Lencioni, MD "New IO Approaches for HCC: An Update on Clinical Trials"

Presentation at the World Conference on Interventional Oncology (WCIO) By Professor Riccardo Lencioni, MD "Advances in Image-Guided Ablation"

Presentation at the World Conference on Interventional Oncology (WCIO) By Professor Ronnie T.P.Poon, MD, PhD "Thermally Sensitive Drug Carriers In Combination with Thermal Ablation"

Presentation at the 2012 Annual Congress of the Cardiovascular and Interventional Radiological Society of Europe by Professor Ronnie T.P. Poon "Thermosensitive Liposome in Combination with Thermal Ablation"